annual net income:
-$69.41M-$17.48M(-33.67%)Summary
- As of today (September 9, 2025), AKBA annual net profit is -$69.41 million, with the most recent change of -$17.48 million (-33.67%) on December 31, 2024.
- During the last 3 years, AKBA annual net income has risen by +$212.61 million (+75.39%).
- AKBA annual net income is now -746.88% below its all-time high of -$8.20 million, reached on December 31, 2012.
Performance
AKBA Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$247.00K-$5.87M(-95.96%)Summary
- As of today (September 9, 2025), AKBA quarterly net profit is $247.00 thousand, with the most recent change of -$5.87 million (-95.96%) on June 1, 2025.
- Over the past year, AKBA quarterly net income has increased by +$8.83 million (+102.88%).
- AKBA quarterly net income is now -99.16% below its all-time high of $29.45 million, reached on June 30, 2022.
Performance
AKBA quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$36.48M+$8.83M(+19.48%)Summary
- As of today (September 9, 2025), AKBA TTM net profit is -$36.48 million, with the most recent change of +$8.83 million (+19.48%) on June 1, 2025.
- Over the past year, AKBA TTM net income has increased by +$3.96 million (+9.79%).
- AKBA TTM net income is now -1020.14% below its all-time high of -$3.26 million, reached on December 1, 2012.
Performance
AKBA TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AKBA Net income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -33.7% | +102.9% | +9.8% |
3 y3 years | +75.4% | -99.2% | +77.5% |
5 y5 years | +75.2% | +100.1% | +90.5% |
AKBA Net income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -33.7% | +75.4% | -99.2% | +100.5% | at high | +77.5% |
5 y | 5-year | -33.7% | +81.9% | -99.2% | +100.1% | at high | +90.7% |
alltime | all time | -746.9% | +81.9% | -99.2% | +100.1% | -1020.1% | +90.7% |
AKBA Net income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $247.00K(-96.0%) | -$36.48M(-19.5%) |
Mar 2025 | - | $6.11M(-126.8%) | -$45.31M(-34.7%) |
Dec 2024 | -$69.41M(+33.7%) | -$22.80M(+13.8%) | -$69.41M(+50.9%) |
Sep 2024 | - | -$20.04M(+133.5%) | -$45.99M(+13.7%) |
Jun 2024 | - | -$8.58M(-52.3%) | -$40.44M(-6.0%) |
Mar 2024 | - | -$17.98M(-3033.9%) | -$43.03M(-17.1%) |
Dec 2023 | -$51.92M(-44.9%) | $613.00K(-104.2%) | -$51.92M(-15.9%) |
Sep 2023 | - | -$14.49M(+29.7%) | -$61.75M(-39.1%) |
Jun 2023 | - | -$11.17M(-58.4%) | -$101.36M(+66.9%) |
Mar 2023 | - | -$26.88M(+191.6%) | -$60.74M(-36.9%) |
Dec 2022 | -$94.23M(-66.6%) | -$9.22M(-83.0%) | -$96.28M(-38.6%) |
Sep 2022 | - | -$54.10M(-283.7%) | -$156.93M(-3.4%) |
Jun 2022 | - | $29.45M(-147.2%) | -$162.38M(-40.9%) |
Mar 2022 | - | -$62.42M(-10.7%) | -$274.87M(-2.5%) |
Dec 2021 | -$282.02M(-26.5%) | -$69.86M(+17.3%) | -$282.02M(-5.7%) |
Sep 2021 | - | -$59.54M(-28.3%) | -$299.16M(-0.1%) |
Jun 2021 | - | -$83.04M(+19.3%) | -$299.58M(-23.6%) |
Mar 2021 | - | -$69.58M(-20.0%) | -$392.29M(+2.3%) |
Dec 2020 | -$383.46M(+37.1%) | -$87.00M(+45.1%) | -$383.46M(-1.9%) |
Sep 2020 | - | -$59.96M(-65.9%) | -$390.94M(+1.4%) |
Jun 2020 | - | -$175.75M(+189.3%) | -$385.57M(+43.9%) |
Mar 2020 | - | -$60.75M(-35.7%) | -$267.99M(-4.2%) |
Dec 2019 | -$279.66M(+94.8%) | -$94.48M(+73.1%) | -$279.66M(+14.0%) |
Sep 2019 | - | -$54.59M(-6.2%) | -$245.23M(+13.2%) |
Jun 2019 | - | -$58.17M(-19.7%) | -$216.69M(+12.5%) |
Mar 2019 | - | -$72.42M(+20.6%) | -$192.59M(+34.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | -$143.59M(+94.9%) | -$60.05M(+130.6%) | -$143.59M(+111.1%) |
Sep 2018 | - | -$26.05M(-23.5%) | -$68.01M(+4.5%) |
Jun 2018 | - | -$34.07M(+45.5%) | -$65.10M(+23.9%) |
Mar 2018 | - | -$23.42M(-250.9%) | -$52.55M(-28.7%) |
Dec 2017 | -$73.67M(-45.7%) | $15.52M(-167.1%) | -$73.67M(-42.0%) |
Sep 2017 | - | -$23.13M(+7.5%) | -$127.06M(-9.4%) |
Jun 2017 | - | -$21.52M(-51.7%) | -$140.23M(-9.2%) |
Mar 2017 | - | -$44.54M(+17.6%) | -$154.49M(+13.8%) |
Dec 2016 | -$135.75M(+123.6%) | -$37.86M(+4.3%) | -$135.75M(+15.3%) |
Sep 2016 | - | -$36.31M(+1.5%) | -$117.74M(+16.7%) |
Jun 2016 | - | -$35.78M(+38.7%) | -$100.91M(+33.1%) |
Mar 2016 | - | -$25.80M(+29.9%) | -$75.82M(+24.9%) |
Dec 2015 | -$60.72M(+63.9%) | -$19.86M(+2.0%) | -$60.72M(+18.5%) |
Sep 2015 | - | -$19.48M(+82.2%) | -$51.23M(+24.6%) |
Jun 2015 | - | -$10.69M(-0.1%) | -$41.10M(+8.1%) |
Mar 2015 | - | -$10.70M(+3.1%) | -$38.03M(-69.3%) |
Dec 2014 | -$37.03M(+181.3%) | -$10.37M(+10.9%) | -$123.93M(+1.1%) |
Sep 2014 | - | -$9.35M(+22.7%) | -$122.54M(+4.8%) |
Jun 2014 | - | -$7.62M(-92.1%) | -$116.96M(+4.3%) |
Mar 2014 | - | -$96.60M(+976.6%) | -$112.17M(+592.7%) |
Dec 2013 | -$13.17M(+60.7%) | -$8.97M(+138.1%) | -$16.19M(+54.6%) |
Sep 2013 | - | -$3.77M(+33.1%) | -$10.48M(+56.2%) |
Jun 2013 | - | -$2.83M(+355.9%) | -$6.71M(+73.0%) |
Mar 2013 | - | -$620.90K(-80.9%) | -$3.88M(+19.1%) |
Dec 2012 | -$8.20M(-55.1%) | - | - |
Dec 2012 | - | -$3.26M | -$3.26M |
Dec 2011 | -$18.27M | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual net profit?
- What is the all time high annual net income for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual net income year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly net profit?
- What is the all time high quarterly net income for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly net income year-on-year change?
- What is Akebia Therapeutics, Inc. TTM net profit?
- What is the all time high TTM net income for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM net income year-on-year change?
What is Akebia Therapeutics, Inc. annual net profit?
The current annual net income of AKBA is -$69.41M
What is the all time high annual net income for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual net profit is -$8.20M
What is Akebia Therapeutics, Inc. annual net income year-on-year change?
Over the past year, AKBA annual net profit has changed by -$17.48M (-33.67%)
What is Akebia Therapeutics, Inc. quarterly net profit?
The current quarterly net income of AKBA is $247.00K
What is the all time high quarterly net income for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly net profit is $29.45M
What is Akebia Therapeutics, Inc. quarterly net income year-on-year change?
Over the past year, AKBA quarterly net profit has changed by +$8.83M (+102.88%)
What is Akebia Therapeutics, Inc. TTM net profit?
The current TTM net income of AKBA is -$36.48M
What is the all time high TTM net income for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM net profit is -$3.26M
What is Akebia Therapeutics, Inc. TTM net income year-on-year change?
Over the past year, AKBA TTM net profit has changed by +$3.96M (+9.79%)